His main research concerns Striatum, Raclopride, Neuroscience, Dopamine and Positron emission tomography. His study in Striatum is interdisciplinary in nature, drawing from both Nucleus accumbens and Globus pallidus. Roger N. Gunn has researched Neuroscience in several fields, including Molecular imaging and Microglia.
Roger N. Gunn combines subjects such as Pharmacology and Putamen with his study of Dopamine. His Positron emission tomography study combines topics from a wide range of disciplines, such as Parametric statistics and Drug discovery. His Nuclear medicine research incorporates elements of Volume of distribution, Biological system, Impulse response and Radioligand.
Roger N. Gunn mainly investigates Positron emission tomography, Pharmacology, Neuroscience, Nuclear medicine and Radioligand. His Positron emission tomography study which covers Pathology that intersects with Microglia, White matter and Multiple sclerosis. His study in Dopamine and Striatum falls within the category of Neuroscience.
His Striatum research incorporates themes from Globus pallidus and Putamen. Within one scientific family, Roger N. Gunn focuses on topics pertaining to Binding potential under Radioligand, and may sometimes address concerns connected to Agonist. As a part of the same scientific family, Roger N. Gunn mostly works in the field of Receptor, focusing on Endocrinology and, on occasion, Serotonin.
Roger N. Gunn spends much of his time researching Internal medicine, Disease, Positron emission tomography, Endocrinology and Neuroimaging. His work carried out in the field of Positron emission tomography brings together such families of science as Biodistribution, Reference Region, Radioligand, Nuclear magnetic resonance and Dosimetry. His Radioligand research integrates issues from Translocator protein, Binding potential, Molecular biology and Human brain.
His work in the fields of Putamen and Dopamine overlaps with other areas such as SV2A. Neuroimaging is a subfield of Neuroscience that Roger N. Gunn investigates. His research in Neuroscience intersects with topics in Centrality and Tau protein.
His primary areas of study are Pathology, Disease, Internal medicine, Positron emission tomography and Volume of distribution. His Internal medicine research includes themes of Gastroenterology, Endocrinology and Neuroimaging. The study incorporates disciplines such as Alzheimer's Disease Neuroimaging Initiative, Oncology, Translocator protein, Neurology and Amyloid in addition to Positron emission tomography.
His Volume of distribution study integrates concerns from other disciplines, such as Receptor, Radioligand, Idiopathic pulmonary fibrosis and Pathogenesis. His biological study spans a wide range of topics, including Molecular biology, Neuroscience, Human brain, Multiple sclerosis and Mitochondrion. His Radioligand study combines topics in areas such as Reference Region, Reliability, Binding potential and 11c pbr28.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis;Vincent Joseph Cunningham;Jacques Delforge;Masahiro Fujita.
Journal of Cerebral Blood Flow and Metabolism (2007)
Evidence for striatal dopamine release during a video game
M. J. Koepp;R. N. Gunn;R. N. Gunn;Andrew David Lawrence;Andrew David Lawrence;V. J. Cunningham;V. J. Cunningham.
In-vivo measurement of activated microglia in dementia
Annachiara Cagnin;David J Brooks;Angus M Kennedy;Roger N Gunn.
The Lancet (2001)
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Roger N. Gunn;Adriaan A. Lammertsma;Susan P. Hume;Vincent J. Cunningham.
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
Paola Piccini;David J. Brooks;Anders Björklund;Roger N. Gunn.
Nature Neuroscience (1999)
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment
Peter A. Sargent;Karen Husted Kjaer;Christopher J. Bench;Eugenii A. Rabiner.
Archives of General Psychiatry (2000)
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
R. B. Banati;J. Newcombe;R. N. Gunn;A. Cagnin.
An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
David R Owen;Astrid J Yeo;Roger N Gunn;Roger N Gunn;Roger N Gunn;Kijoung Song.
Journal of Cerebral Blood Flow and Metabolism (2012)
Positron Emission Tomography Compartmental Models
Roger N. Gunn;Steve R. Gunn;Vincent J. Cunningham.
Journal of Cerebral Blood Flow and Metabolism (2001)
Modeling Sensitization to Stimulants in Humans: An [11C]Raclopride/Positron Emission Tomography Study in Healthy Men
Isabelle Boileau;Alain Dagher;Marco Leyton;Roger N. Gunn.
Archives of General Psychiatry (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: